awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30620954-B7CDB650-B1CD-4F93-A514-DE1DA2EEF023
Q30620954-B7CDB650-B1CD-4F93-A514-DE1DA2EEF023
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30620954-B7CDB650-B1CD-4F93-A514-DE1DA2EEF023
Use of preclinical data for selection of a phase II/III dose for evernimicin and identification of a preclinical MIC breakpoint
P2860
Q30620954-B7CDB650-B1CD-4F93-A514-DE1DA2EEF023
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30620954-B7CDB650-B1CD-4F93-A514-DE1DA2EEF023
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cfa3c1ad96fc289921930f0ee6f607b55e6f1626
P2860
Antimicrobial activity of SCH27899 (Ziracin), a novel everninomicin derivative, tested against Streptococcus spp.: disk diffusion/etest method evaluations and quality control guidelines. The Quality Control Study Group.